US COPD Coalition

Year: 2017

Oct
13

U.S. COPD Coalition Chairman Honored in Indianapolis

The Lambda Beta National Honor Society for Respiratory Care has honored Sam Giordano, MBA, RRT, FAARC. Chair of the U.S. COPD Coalition, with the National Honorary Member Award for his years of dedicated service to the respiratory therapy profession. The award was presented to Mr. Giordano on October 4th at the Lambda Beta Society reception … Read more

Oct
11

3rd Annual Patient Advocacy Summit Held in Indy

Patients, caregivers and clinicians gathered in Indianapolis on October 3, 2017 for the 3rd annual Patient Advocacy Summit. Held in conjunction with the American Association for Respiratory Care’s 63rd International Respiratory Congress and Exhibition, the summit offered attendees the opportunity to collaborate on ways to advocate for advancing the quality of respiratory care for patients suffering … Read more

Sep
20

2016 NIH COPD Survey Results

Click here to see the results of the National Institutes of Health’s 2016 COPD awareness survey entitled “COPD: Tracking Perceptions of Individuals Affected, Their Caregivers, and the Physicians Who Diagnose and Treat Them”

Sep
19

National Institutes of Health Releases COPD Survey Results

The National Institutes of Health (NIH) has released the results of its 2016 COPD awareness survey. The survey, titled COPD – Tracking Perceptions of Individuals Affected, Their Caregivers, and the Physicians Who Diagnose and Treat Them, discusses the current perceptions of those affected by COPD, including patients, caregivers and physicians. Highlights of the report include: 3 … Read more

Sep
13

U.S. COPD Coalition Issues Statement in Response to Long-Term Oxygen (LOTT) Study

Sam Giordano, MBA, RRT, FAARC, Chair of the U.S. COPD Coalition (USCC), has issued an official statement on behalf of the USCC Board of Directors in response to the recent release of the Randomized Trial of Long- Term Oxygen for COPD with Moderate Desaturation study: Impact of the Most Recent Lott Study(Randomized Trial of Long- Term Oxygen … Read more

Sep
12

Understanding Medicare Drug Coverage

Understanding your insurance coverage for your medications when you have Medicare can be a challenge. The Centers for Medicare and Medicaid Services has a helpful summary that explains the different coverage under the various plans. Click this link for helpful information on Medicare drug coverage: Medicare Drug Coverage under Medicare Part A, Part B, Part … Read more

Sep
12

CMS Releases Helpful Guide to Understaning Medicare Drug Coverage

Trying to understand your medication coverage under Medicare Parts A, B, C, and D can be daunting, but help is at hand. The Centers for Medicare & Medicaid Services has just released a helpful guide that explains Medicare drug coverage under the various parts of the plan. The guide, Medicare Drug Coverage under Medicare Part A, … Read more

Sep
6

Questions to Ask Your Doctor

The U.S. Department of Health & Human Services Agency for Healthcare Research and Quality (AHRQ) wants you to know that asking questions of your doctor and providing information helps you get better care. According to the AHRQ’s website, “Asking questions and providing information to your doctor and other care providers can improve your care. Talking with your … Read more

Aug
24

COPD and Vaccines – CDC Recommendations

If you have chronic lung disease, the Centers for Disease Control and Prevention (CDC) recommends that you get vaccinated against certain preventable diseases. At a minimum, the CDC recommends the following immunizations: Influenza Vaccine – Needed yearly to protect against seasonal flu TDAP Vaccine – To protect against tetanus, diptheria and pertussis (whooping cough) Pneumococcal Vaccine – To … Read more

Aug
21

FDA Seeks Input into Direct-to-Consumer Drug Advertising

Food & Drug Commissioner Scott Gottlieb, M.D., wants to hear from consumers and the medical community regarding the warning messages that accompany drugs that are marketed directly to consumers.   “In addition to providing consumers with the benefits of the potential treatment, today’s direct-to-consumer prescription drug advertisements must also present the risks. But if the … Read more